Janssen to stop further development of JNJ-4178 hepatitis C treatment
Janssen Sciences Ireland has taken a strategic decision to discontinue further development of its investigational regimen JNJ-4178 for the treatment of patients with hepatitis C. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
Pascal Biosciences acquires STC technology for B-cell precursor ALL treatment
Canadian drug discovery and development company Pascal Biosciences has executed an exclusive, worldwide licence option agreement with STC.UNM (STC) to purchase a therapeutic monoclonal antibody for B-cell precursor acute lymphoblastic leukaemia (BCP- … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
MUNIT to Attend PharmaChemOutsourcing
MUNIT has announced its commercial director Mr Schiavazzi will be attending PharmaChemOutsourcing at Long Beach, New Jersey. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
PQG 40th Anniversary Dinner and Meeting, Milton Keynes
To celebrate its 40th anniversary, the Pharmaceutical Quality Group (PQG) is holding an anniversary dinner and a three-day meeting at the Hilton Hotel in Milton Keynes, UK. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
CARB-X Chief Strategy Officer John Rex to Open Superbugs USA Summit
Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level. Superbugs and Superdrugs USA, will dis … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
SCRO 2015/16 Annual Review
SCRO had an exciting year, focusing strongly on its growth and presence in the Nordic region. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
SA Vision Finds Technology is Biggest Barriers to Serialisation in the Pharmaceutical Industry
Industry research conducted by SEA Vision and Zenith Technology found technology to be the greatest barrier to serialisation success, cited by 28% of respondents. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 12, 2017 Category: Pharmaceuticals Source Type: news
One in five: why the UK pharma industry is going to court over spending caps
The ABPI is taking UK drug regulator NICE to court over new spending caps, which will affect one in five of all new approved drugs. Abi Millar looks into the issues surrounding this important legal contest. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Integra to sell neurosurgery assets to Natus Medical
Integra LifeSciences has signed an agreement to sell certain neurosurgery assets to Natus Medical in a deal valued at $47.5m. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Vanderbilt University and Bayer to evaluate new drug candidates for kidney diseases
Vanderbilt University Medical Center (VUMC) and Bayer are set to form a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Summit Therapeutics secures $62m contract to develop ridinilazole for CDI treatment
UK-based drug discovery and development company Summit Therapeutics has secured a contract worth up to $62m to support the clinical and regulatory development of ridinilazole for the treatment of C. difficile infection (CDI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Alewife Research Centre (ARC), Cambridge
The Davis Companies (TDC) has developed a new research centre in West Cambridge, Massachusetts. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Novo Nordisk Pharmaceuticals High-Quality Ingredients
Every new idea needs great execution. Novo Nordisk Pharmaceuticals can help with a reliable supply of the highest quality ingredients for the biopharmaceutical and pharmaceutical industries. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news
Regeneron and Sanofi receive FDA ’s breakthrough therapy status for CSCC treatment with cemiplimab
US-based Regeneron Pharmaceuticals and French company Sanofi have received breakthrough therapy designation status for cemiplimab (REGN2810) from the US Food and Drug Administration (FDA) to treat cutaneous squamous cell carcinoma (CSCC). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 10, 2017 Category: Pharmaceuticals Source Type: news
Merck and Project Data Sphere to join forces to lead Big Data alliance
Science and technology company Merck and Project Data Sphere are set to collaborate to jointly lead the Global Oncology Big Data Alliance (GOBDA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 10, 2017 Category: Pharmaceuticals Source Type: news
